Discontinuation report DEXTROSE INJECTION USP
| Report ID | 233049 |
| Drug Identification Number | 00037966 |
| Brand name | DEXTROSE INJECTION USP |
| Common or Proper name | Dextrose Injection USP |
| Company Name | ICU MEDICAL CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXTROSE |
| Strength(s) | 200MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 500 mL in 500 mL |
| ATC code | B05BA |
| ATC description | I.V. SOLUTIONS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2024-10-31 |
| Actual discontinuation date | 2025-02-06 |
| Remaining supply date | 2024-10-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Last lot expires 31-Oct-2024 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2600 BOUL ALFRED-NOBEL, SUITE 100 SAINT LAURENT, QUEBEC CANADA H4S 0A9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-02-20 | French | Compare |
| v3 | 2025-02-20 | English | Compare |
| v2 | 2024-07-16 | French | Compare |
| v1 | 2024-07-16 | English | Compare |
Showing 1 to 4 of 4